Evaluation of a new ELISA assay for monoclonal free‐light chain detection in patients with cardiac amyloidosis. Issue 3 (24th June 2022)
- Record Type:
- Journal Article
- Title:
- Evaluation of a new ELISA assay for monoclonal free‐light chain detection in patients with cardiac amyloidosis. Issue 3 (24th June 2022)
- Main Title:
- Evaluation of a new ELISA assay for monoclonal free‐light chain detection in patients with cardiac amyloidosis
- Authors:
- Abroud, Hajer
Beldi‐Ferchiou, Asma
Audard, Vincent
Lemonnier, François
Le Bras, Fabien
Belhadj, Karim
Moktefi, Anissa
Poullot, Elsa
El Karoui, Khalil
Dupuis, Jehan
Maarek, Alizée
Roulin, Louise
Delfau‐Larue, Marie‐Hélène
Oghina, Silvia
Kharoubi, Mounira
Bézard, Mélanie
Zaroui, Amira
Damy, Thibaud
Molinier‐Frenkel, Valérie - Abstract:
- Abstract: The causal protein of amyloid light‐chain (AL) amyloidosis is a monoclonal immunoglobulin free light chain (mFLC), which must be quantified in the serum for patient diagnosis and monitoring. Several manufacturers commercialize immunoassays that quantify total kappa (κ) and lambda (λ) FLC, but results can differ greatly between these tests. Here, we compared a recently developed enzyme‐linked immunosorbent assay (ELISA) (Sebia) with N‐Latex immunonephelometry (Siemens) in 96 patients diagnosed with AL amyloidosis (histologically confirmed) and 48 non‐AL patients sent to our referral center for suspicion of cardiac amyloidosis. ELISA free‐light chain difference (dFLC) were lower than N‐Latex values, and agreement between methods was reduced in the case of involved λ FLC. Diagnosis sensitivity and specificity were >85% with both assays. A receiver operating characteristic analysis indicated that ELISA performances could be improved by using a higher value for the lower limit of the κ/λ ratio. We also assessed Freelite (The Binding Site) in a subgroup of these same AL patients, including 18 cases with normal κ/λ ratio by at least one assay. Only two patients had normal κ/λ ratio with all three assays. Overall, ELISA demonstrated slightly lower sensitivity than N‐Latex but may be an alternative to nephelometry/turbidimetry in certain difficult cases.
- Is Part Of:
- EJHaem. Volume 3:Issue 3(2022)
- Journal:
- EJHaem
- Issue:
- Volume 3:Issue 3(2022)
- Issue Display:
- Volume 3, Issue 3 (2022)
- Year:
- 2022
- Volume:
- 3
- Issue:
- 3
- Issue Sort Value:
- 2022-0003-0003-0000
- Page Start:
- 828
- Page End:
- 837
- Publication Date:
- 2022-06-24
- Subjects:
- AL amyloidosis -- cardiac amyloidosis -- ELISA -- free‐light chain -- monoclonal gammopathy
Hematology -- Periodicals
616.15 - Journal URLs:
- http://onlinelibrary.wiley.com/ ↗
https://onlinelibrary.wiley.com/journal/26886146 ↗ - DOI:
- 10.1002/jha2.516 ↗
- Languages:
- English
- ISSNs:
- 2688-6146
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 23211.xml